Prosensa : Franchise Herald

Prosensa

Prosensa

BioMarin Buys Prosensa for $840 Million, Push Approval of Muscular Dystrophy Drug

BioMarin Pharmaceutical Inc., a manufacturer that primarily makes rare diseases, shelled out $840 million to buy Prosensa Holding NV, an emerging Dutch biopharmaceutical company in an effort to push for approval of drug against muscular dystrophy.

Just In

Costco's Legendary Return Policy Strikes Again: 2017 Purchase Refunded in Full

Costco Wholesale

Dollar Tree Announces Closure of 35 Stores in Ohio, Final Sales Underway

Sorry We're Closed Note

Walmart Continues Downsize with Latest Store Closure, 105 Employees Affected

Shopping trolley

Steak 'N Shake Introduces Facial Recognition Payment System, Sparks Customer Outrage

Sliced Steak

Chili’s Restaurant Closes Permanently, Locals Reflect on Memories

Fixed chairs

Most Read

1

Foxtrot's Last Call: 33 Stores Close Without Warning, Disrupting Customers' Coffee Rituals

Two people in a coffee shop

2

Express to Close Stores Nationwide, Files for Bankruptcy Protection

Black plastic hangers

3

Walmart Streamlines Operations, Announces Closure of Another Store, Affecting Local Job Market

Organized Shopping carts

4

Fareway's Growth Continues with Upcoming Store in Coal Valley

Open sign

5

True Value Bids Farewell: Iconic Store Location Closes Permanently, Liquidation Sales Offer Up to 50% Off

Locked door